0001236031-13-000020.txt : 20130703 0001236031-13-000020.hdr.sgml : 20130703 20130703134313 ACCESSION NUMBER: 0001236031-13-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130701 FILED AS OF DATE: 20130703 DATE AS OF CHANGE: 20130703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE CLARA MAXIMILIAN CENTRAL INDEX KEY: 0001236031 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 13952517 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-07-01 0 0000725363 CEL SCI CORP cvm 0001236031 DE CLARA MAXIMILIAN 1 1 0 0 President Options 0.21 2013-07-01 4 A 0 375000 0 A 2023-06-30 Common Stock 375000 5458249 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Maximilian de Clara 2013-07-03